Brokerages expect Medical Properties Trust, Inc. (NYSE:MPW) to announce sales of $161.29 million for the current fiscal quarter, Zacks reports. Six analysts have issued estimates for Medical Properties Trust’s earnings, with the lowest sales estimate coming in at $156.75 million and the highest estimate coming in at $170.32 million. Medical Properties Trust reported sales of $126.30 million in the same quarter last year, which indicates a positive year-over-year growth rate of 27.7%. The company is expected to issue its next quarterly earnings results on Thursday, August 3rd.

According to Zacks, analysts expect that Medical Properties Trust will report full-year sales of $161.29 million for the current financial year, with estimates ranging from $628.40 million to $679.07 million. For the next financial year, analysts anticipate that the company will post sales of $691.67 million per share, with estimates ranging from $631.37 million to $738.22 million. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that that provide coverage for Medical Properties Trust.

Medical Properties Trust (NYSE:MPW) last announced its quarterly earnings data on Thursday, May 4th. The real estate investment trust reported $0.33 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.33. Medical Properties Trust had a net margin of 41.79% and a return on equity of 7.94%. The business had revenue of $156.40 million during the quarter, compared to analyst estimates of $156.91 million. During the same period last year, the firm posted $0.35 EPS. The company’s revenue was up 15.9% on a year-over-year basis.

Several research analysts have recently weighed in on MPW shares. Robert W. Baird started coverage on Medical Properties Trust in a research note on Thursday, March 9th. They set an “outperform” rating and a $14.00 target price for the company. Deutsche Bank AG upped their target price on Medical Properties Trust from $13.50 to $15.00 and gave the stock a “buy” rating in a research note on Thursday, April 6th. Jefferies Group LLC raised Medical Properties Trust from a “hold” rating to a “buy” rating and upped their target price for the stock from $13.00 to $15.00 in a research note on Friday, April 7th. Royal Bank Of Canada reaffirmed a “buy” rating on shares of Medical Properties Trust in a research note on Monday, May 15th. Finally, ValuEngine downgraded Medical Properties Trust from a “buy” rating to a “hold” rating in a research note on Friday, June 2nd. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have assigned a buy rating to the company. Medical Properties Trust currently has a consensus rating of “Hold” and an average target price of $14.22.

ILLEGAL ACTIVITY NOTICE: This piece was originally reported by American Banking News and is owned by of American Banking News. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2017/07/07/161-29-million-in-sales-expected-for-medical-properties-trust-inc-mpw-this-quarter.html.

In other Medical Properties Trust news, CFO R Steven Hamner sold 85,000 shares of the company’s stock in a transaction on Wednesday, June 14th. The stock was sold at an average price of $13.36, for a total value of $1,135,600.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.00% of the stock is owned by corporate insiders.

Several institutional investors have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP boosted its position in Medical Properties Trust by 28.3% in the fourth quarter. Dimensional Fund Advisors LP now owns 4,114,144 shares of the real estate investment trust’s stock worth $50,604,000 after buying an additional 907,497 shares in the last quarter. Federated Investors Inc. PA boosted its position in Medical Properties Trust by 0.9% in the fourth quarter. Federated Investors Inc. PA now owns 133,588 shares of the real estate investment trust’s stock worth $1,643,000 after buying an additional 1,238 shares in the last quarter. Credit Agricole S A boosted its position in Medical Properties Trust by 61.1% in the fourth quarter. Credit Agricole S A now owns 221,919 shares of the real estate investment trust’s stock worth $2,729,000 after buying an additional 84,125 shares in the last quarter. New York State Teachers Retirement System boosted its position in Medical Properties Trust by 15.9% in the fourth quarter. New York State Teachers Retirement System now owns 398,931 shares of the real estate investment trust’s stock worth $4,907,000 after buying an additional 54,800 shares in the last quarter. Finally, Envestnet Asset Management Inc. boosted its position in Medical Properties Trust by 3.1% in the fourth quarter. Envestnet Asset Management Inc. now owns 19,565 shares of the real estate investment trust’s stock worth $241,000 after buying an additional 588 shares in the last quarter. Institutional investors and hedge funds own 78.42% of the company’s stock.

Shares of Medical Properties Trust (MPW) traded up 1.38% during midday trading on Friday, reaching $12.51. 1,650,261 shares of the company’s stock were exchanged. The stock has a market cap of $4.02 billion, a P/E ratio of 15.02 and a beta of 0.89. Medical Properties Trust has a one year low of $11.54 and a one year high of $15.92. The company’s 50-day moving average is $13.20 and its 200-day moving average is $12.96.

The business also recently announced a quarterly dividend, which will be paid on Friday, July 14th. Shareholders of record on Thursday, June 15th will be issued a $0.24 dividend. This represents a $0.96 annualized dividend and a yield of 7.78%. The ex-dividend date is Tuesday, June 13th. Medical Properties Trust’s payout ratio is currently 114.29%.

About Medical Properties Trust

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

Get a free copy of the Zacks research report on Medical Properties Trust (MPW)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.